Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons (original) (raw)

• Lambert, M.P. et al. Diffusible, nonfibrillar ligands derived from Abeta1–42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448–6453 (1998).
  Article CAS Google Scholar
• Walsh, D.M. et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535–539 (2002).
  Article CAS Google Scholar
• Shankar, G.M. et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837–842 (2008).
  Article CAS Google Scholar
• Lesné, S. et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352–357 (2006).
  Article Google Scholar
• Laurén, J., Gimbel, D.A., Nygaard, H.B., Gilbert, J.W. & Strittmatter, S.M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128–1132 (2009).
  Article Google Scholar
• Zou, W.Q. et al. Amyloid-{beta}42 interacts mainly with insoluble prion protein in the alzheimer brain. J. Biol. Chem. 286, 15095–15105 (2011).
  Article CAS Google Scholar
• Balducci, C. et al. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. USA 107, 2295–2300 (2010).
  Article CAS Google Scholar
• Chen, S., Yadav, S.P. & Surewicz, W.K. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role of N-terminal residues. J. Biol. Chem. 285, 26377–26383 (2010).
  Article CAS Google Scholar
• Calella, A.M. et al. Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol. Med. 2, 306–314 (2010).
  Article CAS Google Scholar
• Freir, D.B. et al. Interaction between prion protein and toxic amyloid beta assemblies can be therapeutically targeted at multiple sites. Nat. Commun. 2, 336 (2011).
  Article Google Scholar
• Cisse, M. et al. Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J. Neurosci. 31, 10427–10431 (2011).
  Article CAS Google Scholar
• Kessels, H.W., Nguyen, L.N., Nabavi, S. & Malinow, R. The prion protein as a receptor for amyloid-beta. Nature 466, E3–4 (2010).
  Article CAS Google Scholar
• Gimbel, D.A. et al. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J. Neurosci. 30, 6367–6374 (2010).
  Article CAS Google Scholar
• Chung, E. et al. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. BMC Neurosci. 11, 130 (2010).
  Article Google Scholar
• Resenberger, U.K. et al. The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO J. 30, 2057–2070 (2011).
  Article CAS Google Scholar
• Barry, A.E. et al. Alzheimer's disease brain–derived amyloid-beta–mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J. Neurosci. 31, 7259–7263 (2011).
  Article CAS Google Scholar
• Bate, C. & Williams, A. Amyloid-beta–induced synapse damage is mediated via cross-linkage of cellular prion proteins. J. Biol. Chem. 286, 37955–37963 (2011).
  Article CAS Google Scholar
• You, H. et al. Abeta neurotoxicity depends on interactions between copper ions, prion protein and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. USA 109, 1737–1742 (2012).
  Article CAS Google Scholar
• Alier, K., Ma, L., Yang, J., Westaway, D. & Jhamandas, J.H. Abeta inhibition of ionic conductance in mouse basal forebrain neurons is dependent upon the cellular prion protein PrPC. J. Neurosci. 31, 16292–16297 (2011).
  Article CAS Google Scholar
• Kudo, W. et al. Cellular prion protein is essential for oligomeric amyloid-beta–induced neuronal cell death. Hum. Mol. Genet. 21, 1138–1144 (2012).
  Article CAS Google Scholar
• Shankar, G.M. et al. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor–dependent signaling pathway. J. Neurosci. 27, 2866–2875 (2007).
  Article CAS Google Scholar
• Lacor, P.N. et al. Abeta oligomer-induced aberrations in synapse composition, shape and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci. 27, 796–807 (2007).
  Article CAS Google Scholar
• Snyder, E.M. et al. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 1051–1058 (2005).
  Article CAS Google Scholar
• Pantera, B. et al. PrPc activation induces neurite outgrowth and differentiation in PC12 cells: role for caveolin-1 in the signal transduction pathway. J. Neurochem. 110, 194–207 (2009).
  Article CAS Google Scholar
• Mouillet-Richard, S. et al. Cellular prion protein signaling in serotonergic neuronal cells. Ann. NY Acad. Sci. 1096, 106–119 (2007).
  Article CAS Google Scholar
• Williamson, R., Usardi, A., Hanger, D.P. & Anderton, B.H. Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism. FASEB J. 22, 1552–1559 (2008).
  Article CAS Google Scholar
• Málaga-Trillo, E. et al. Regulation of embryonic cell adhesion by the prion protein. PLoS Biol. 7, e55 (2009).
  Article Google Scholar
• Bizat, N. et al. Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans. J. Neurosci. 30, 5394–5403 (2010).
  Article CAS Google Scholar
• Suzuki, T. & Okumura-Noji, K. NMDA receptor subunits epsilon 1 (NR2A) and epsilon 2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain. Biochem. Biophys. Res. Commun. 216, 582–588 (1995).
  Article CAS Google Scholar
• Grant, S.G. et al. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258, 1903–1910 (1992).
  Article CAS Google Scholar
• Nakazawa, T. et al. Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 276, 693–699 (2001).
  Article CAS Google Scholar
• Chin, J. et al. Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 25, 9694–9703 (2005).
  Article CAS Google Scholar
• Renner, M. et al. Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron 66, 739–754 (2010).
  Article CAS Google Scholar
• Collins, M.O. et al. Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. J. Neurochem. 97 Suppl 1, 16–23 (2006).
  Article CAS Google Scholar
• Stuermer, C.A. et al. PrPc capping in T cells promotes its association with the lipid raft proteins reggie-1 and reggie-2 and leads to signal transduction. FASEB J. 18, 1731–1733 (2004).
  Article CAS Google Scholar
• Salter, M.W. & Kalia, L.V. Src kinases: a hub for NMDA receptor regulation. Nat. Rev. Neurosci. 5, 317–328 (2004).
  Article CAS Google Scholar
• Zhang, Y. et al. Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model. Proc. Natl. Acad. Sci. USA 107, 19014–19019 (2010).
  Article CAS Google Scholar
• Prybylowski, K. et al. The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron 47, 845–857 (2005).
  Article CAS Google Scholar
• Chen, P., Gu, Z., Liu, W. & Yan, Z. Glycogen synthase kinase 3 regulates N-methyl-D-aspartate receptor channel trafficking and function in cortical neurons. Mol. Pharmacol. 72, 40–51 (2007).
  Article CAS Google Scholar
• Scheff, S.W., DeKosky, S.T. & Price, D.A. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol. Aging 11, 29–37 (1990).
  Article CAS Google Scholar
• Palop, J.J. et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55, 697–711 (2007).
  Article CAS Google Scholar
• Minkeviciene, R. et al. Amyloid beta–induced neuronal hyperexcitability triggers progressive epilepsy. J. Neurosci. 29, 3453–3462 (2009).
  Article CAS Google Scholar
• McDonald, J.M. et al. The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain 133, 1328–1341 (2010).
  Article Google Scholar
• Steinerman, J.R. et al. Distinct pools of beta-amyloid in Alzheimer disease–affected brain: a clinicopathologic study. Arch. Neurol. 65, 906–912 (2008).
  Article Google Scholar
• Kuo, Y.M. et al. Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077–4081 (1996).
  Article CAS Google Scholar
• Peng, J. et al. Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J. Biol. Chem. 279, 21003–21011 (2004).
  Article CAS Google Scholar
• Yoshimura, Y. et al. Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-tandem mass spectrometry. J. Neurochem. 88, 759–768 (2004).
  Article CAS Google Scholar
• Li, S. et al. Soluble A{beta} oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J. Neurosci. 31, 6627–6638 (2011).
  Article CAS Google Scholar
• Kojima, N., Ishibashi, H., Obata, K. & Kandel, E.R. Higher seizure susceptibility and enhanced tyrosine phosphorylation of N-methyl-D-aspartate receptor subunit 2B in fyn transgenic mice. Learn. Mem. 5, 429–445 (1998).
  CAS PubMed PubMed Central Google Scholar
• Ittner, L.M. et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142, 387–397 (2010).
  Article CAS Google Scholar
• Stein, P.L., Lee, H.M., Rich, S. & Soriano, P. pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 70, 741–750 (1992).
  Article CAS Google Scholar
• Zahn, R., von Schroetter, C. & Wuthrich, K. Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding. FEBS Lett. 417, 400–404 (1997).
  Article CAS Google Scholar